T 100 (Tarceva 100 mg)

Generic Name: erlotinib

Pill imprint T 100 has been identified as Tarceva 100 mg.

Tarceva is used in the treatment of non-small cell lung cancer; pancreatic cancer; renal cell carcinoma and belongs to the drug class EGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Tarceva 100 mg is not a controlled substance under the Controlled Substance Act (CSA).

Tarceva

Generic Name:

erlotinib

Imprint:

T 100

Strength:

100 mg

Color:

White

Size:

9.00 mm

Shape:

Round

Availability:

Prescription only

Drug Class:

EGFR inhibitors

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Manufacturer:

Genentech

National Drug Code (NDC):

50242-0063

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
54868-5474	Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.